- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03684486
Rehabilitation by Effort for Patients With Advanced Bronchial Cancer (RehabKBP)
April 29, 2026 updated by: University Hospital, Toulouse
Bronchopulmonary cancers or mesothelioma are associated with effort deconditioning due to pathology (chronic inflammation) and also to treatments (surgery, radiotherapy, chemotherapy); it's considerably alters patients quality of life.
Investigators want to ensured the feasibility of rehabilitation by effort for these patients.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
19
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
France
-
Toulouse, France, France, 31059
- CHU de Toulouse
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- General condition according to World Health Organisation 0-1
- Age between 18 and 70 years old
- Non progressive patients according to RECIST criteria 1.1 after chemotherapy treatment whichever line of treatment
- Autonomous patient
- Voluntary written informed consent signed
- Patients with social security insurance
Exclusion Criteria:
- Bone metastasis with fracture risk
- Significant cardiovascular pathology
- Cardiac, vascular, rheumatologic or neurologic contraindication
- Patients living far 60 kms from Toulouse
- Patients under juridical protection guardianship, or tutelage measure
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: rehabilitation by effort
8 sessions of rehabilitation by effort in sports medicine
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
patients who completed at least 6 sessions of rehabilitation
Time Frame: 10 years
|
number of patients who completed at least 6 sessions of rehabilitation by effort
|
10 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Julien Mazières, MD PhD, University Hospital, Toulouse
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2012
Primary Completion (Actual)
July 24, 2019
Study Completion (Actual)
July 24, 2019
Study Registration Dates
First Submitted
September 24, 2018
First Submitted That Met QC Criteria
September 24, 2018
First Posted (Actual)
September 25, 2018
Study Record Updates
Last Update Posted (Actual)
May 6, 2026
Last Update Submitted That Met QC Criteria
April 29, 2026
Last Verified
April 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Neoplasms by Site
- Neoplasms
- Respiratory Tract Diseases
- Neoplasms by Histologic Type
- Lung Diseases
- Neoplasms, Glandular and Epithelial
- Respiratory Tract Neoplasms
- Thoracic Neoplasms
- Lung Neoplasms
- Adenoma
- Neoplasms, Mesothelial
- Pleural Neoplasms
- Bronchial Neoplasms
- Mesothelioma
- Mesothelioma, Malignant
- Carcinoma, Bronchogenic
Other Study ID Numbers
- RC31/11/0087
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.